BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181211
DTEND;VALUE=DATE:20181214
DTSTAMP:20260515T005718
CREATED:20181031T155925Z
LAST-MODIFIED:20181031T160117Z
UID:18205-1544486400-1544745599@www.pharmajournalist.com
SUMMARY:Tumor Targeted Lymphocyte Summit
DESCRIPTION:The Tumor Targeted Lymphocyte Summit is the first\, dedicated meeting that unites the expert community working in TIL and CTL therapies to network\, learn and determine strategies to enhance the efficacy of this adoptive cell therapy in solid tumors. \n \nAs CAR-T fails in the fight to deliver efficacy in solid tumors\, the field is desperately exploring alternative adoptive cell therapies which are strong enough to rise to the challenge. TILs and CTLs have successfully been utilized in melanoma and now with patient demand growing\, TIL-based therapies are fast becoming a more attractive approach to solid tumors. \nSounds interesting? Find out more – get free event brochure here: http://bit.ly/2zgKRSx
URL:https://www.pharmajournalist.com/event/tumor-targeted-lymphocyte-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181212
DTEND;VALUE=DATE:20181214
DTSTAMP:20260515T005718
CREATED:20181005T130934Z
LAST-MODIFIED:20181005T130934Z
UID:17934-1544572800-1544745599@www.pharmajournalist.com
SUMMARY:7th Lung Cancer Screening & Continuum of Care
DESCRIPTION:ACI is excited to announce our 7th Lung Cancer Screening & Continuum of Care Conference on December 12-13\, 2018. A dedicated forum to learn and network with representatives from organizations nationwide that are prepared to deliver superior service in thoracic oncology. \nOur event will be an exploration of techniques and policy changes to better fit lung screening programs through case studies\, research findings and organizational models from renowned healthcare and radiology institutions. The top thoracic oncology programs in the country will showcase their successes and share strategies in achieving excellence in patient care and cost-effective management. \n \nThis two-day event will focus on implementing lung screening programs and services to maximize competitive advantage\, meet increased demand and exceed patient satisfaction. The goal of this event is to bring industry leaders together\, highlight the best practice achievements\, and discuss the current issues and developments in imaging services for the thoracic oncology community. \nLung cancer is the leading cause of cancer-related deaths in the United States. This largely stems from lung cancer’s minimal symptoms in its early stages\, which is when the disease is most treatable. For this reason\, there is a push for regions to offer screening services for their populations\, enabling potential patients to receive care at the most opportune time. Providing this service to potential patients comes with its own challenges\, such as motivating patients to get screened regularly\, generating funding for these services\, raising awareness in your community and many more.
URL:https://www.pharmajournalist.com/event/7th-lung-cancer-screening-continuum-of-care/
LOCATION:Tampa\, FL\, USA\, FL\, United States
ORGANIZER;CN="ACI":MAILTO:rafael@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181212
DTEND;VALUE=DATE:20181214
DTSTAMP:20260515T005718
CREATED:20181025T095842Z
LAST-MODIFIED:20181025T095842Z
UID:18110-1544572800-1544745599@www.pharmajournalist.com
SUMMARY:AI & Big Data for Pharma\, part of DATAx
DESCRIPTION:AI & Big Data for Pharma Summit 2018: Leverage Data Analytics to Deliver Patient-Centric Outcomes \n \nWith the race to adopt data and analytics\, the pharma ecosystem is transforming to keep up with the rapid pace of change. Unprecedented volumes of real-time data are right at our fingertips\, leaders must think strategically about how to gather\, harvest\, and leverage insights. The is the must-attend event to enhance AI and analytics capability in drug discovery and development\, translate patient data into meaningful insights\, and master the art of a seamless journey in pharma supply chain and logistics. \nTopic Areas Covered Include: \n\nLeveraging real time data in R&D and challenges of unstructured data\nAccelerating drug discovery and development through advanced analytics\nStreamlining clinical trial efficiency using AI and machine learning\nCultivating industry partnerships to build knowledge networks\nThe changing face of pharma and how the industry is evolving\nRise of the digital patient: Personalised patient care\, precision medicine and AI\nManaging demand forecasting\, planning\, and reduce waste in commercial analytics\nTransparency in the global supply chain and optimising robotics and AI\n\nFind out more information and register here: http://bit.ly/2O3MQ1Z
URL:https://www.pharmajournalist.com/event/ai-big-data-for-pharma/
LOCATION:New York Hilton Midtown
ORGANIZER;CN="The Innovation Enterprise Ltd.":MAILTO:http://bit.ly/2O3MQ1Z
END:VEVENT
END:VCALENDAR